Tickerplace logo

Tickerplace

Kiniksa Pharmaceuticals, Ltd. logo

KNSAKiniksa Pharmaceuticals, Ltd.

KNSA Stock Price, Valuation & Chart | Kiniksa Pharmaceuticals, Ltd.

Compare
$79.890+0.61 (+0.77%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyKNSA intrinsic valueKNSA calculated fair value vs price
OverviewFinancialsDividendsRatios

KNSA Historical price chart

KNSA Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization6.09B
PE Ratio88.77
EPS0.9
Trading Volume568.43K
Today's High/Low80.18/77.87
Dividend Yield0.00
52 Week High/Low82.94/34.0
Shares Outstanding76.21M
KNSA Financial Statement
KNSA Analyst ratings
KNSA Analysis & performance metrics

KNSA Company profile

Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering…

KNSA Management team

Management
Jonathan Kirshenbaum
Investor Relations Officer
John F. Paolini FACC, M.D., Ph.D.
Executive Vice President & Chief Medical Officer
Chad Morin
Senior Vice President & Chief Compliance Officer
Eben TessariCOO
Executive Vice President & Chief Operating Officer
Mei Jang
Senior Vice President of Technical Operations
Michael R. Megna CPA
Chief Accounting Officer & Group Vice President of Finance
Sanj K. PatelCEO
Chief Executive Officer & Chairman of the Board
Madelyn Demsky Zeylikman
SVice President, General Counsel & Secretary
Total 8 executives

KNSA Frequently asked questions

What is Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Price?

Current stock price of Kiniksa Pharmaceuticals, Ltd. (KNSA) stock is $79.890. The stock price is +0.77% higher in the session. The intraday range can be seen from this page. Volume of Kiniksa Pharmaceuticals, Ltd. (KNSA) stock is 568.43K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Kiniksa Pharmaceuticals, Ltd. (KNSA) stock price going up or down today?

The stock price of Kiniksa Pharmaceuticals, Ltd. (KNSA) can change with earnings, company news, and overall market sentiment. Kiniksa Pharmaceuticals, Ltd. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Kiniksa Pharmaceuticals, Ltd. stock expensive at its current price?

Whether Kiniksa Pharmaceuticals, Ltd. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for KNSA on this page is 88.77. EPS on this page is 0.90. Compare those figures with peers and growth expectations before deciding if the current Kiniksa Pharmaceuticals, Ltd. price is justified.

How has the stock price of Kiniksa Pharmaceuticals, Ltd. (KNSA) performed historically?

Historical performance for Kiniksa Pharmaceuticals, Ltd. (KNSA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how KNSA reacted to past earnings and market events.

Should I buy Kiniksa Pharmaceuticals, Ltd. (KNSA) stock, at this price?

Buying Kiniksa Pharmaceuticals, Ltd. (KNSA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.